Castle Hook Partners’s Regenxbio RGNX Stock Holding History

Castle Hook Partners’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-150,000	Closed	-$2.96M	–	74
2017 Q2	$2.96M	Buy	150,000 +90,000	+150%	+$1.74M	0.19%	44
2017 Q1	$1.16M	Buy	+60,000	New	+$1.16M	0.06%	49

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Castle Hook Partners's RGNX Position: Q3 2017 in Review

Castle Hook Partners sold out of Regenxbio (RGNX) in Q3 2017, closing a stake of 150,000 shares — an estimated $2.96M sold.

Castle Hook Partners first reported a position in RGNX in Q1 2017 and held it in 2 quarters. The position peaked at $2.96M in Q2 2017. 89 funds tracked by Wall St. Rank hold RGNX as of Q3 2017.

Castle Hook Partners reported no remaining Regenxbio position as of Q3 2017 after selling out during the quarter.
Castle Hook Partners sold 150,000 Regenxbio shares in Q3 2017, an estimated $2.96M.
Castle Hook Partners first reported a position in Regenxbio in Q1 2017 and held it in 2 quarters.
Castle Hook Partners's Regenxbio position peaked at $2.96M in Q2 2017.
89 funds tracked by Wall St. Rank held Regenxbio as of Q3 2017.

Based on Castle Hook Partners's 13F filing for Q3 2017, filed 14 Nov 2017.